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Abstract
The purpose of this review is to examine vitamin D in the context of sport nutrition and its potential role in
optimizing athletic performance. Vitamin D receptors (VDR) and vitamin D response elements (VDREs) are located in
almost every tissue within the human body including skeletal muscle. The hormonally-active form of vitamin D,
1,25-dihydroxyvitamin D, has been shown to play critical roles in the human body and regulates over 900 gene
variants. Based on the literature presented, it is plausible that vitamin D levels above the normal reference range
(up to 100 nmol/L) might increase skeletal muscle function, decrease recovery time from training, increase both
force and power production, and increase testosterone production, each of which could potentiate athletic
performance. Therefore, maintaining higher levels of vitamin D could prove beneficial for athletic performance.
Despite this situation, large portions of athletic populations are vitamin D deficient. Currently, the research is
inconclusive with regards to the optimal intake of vitamin D, the specific forms of vitamin D one should ingest, and
the distinct nutrient-nutrient interactions of vitamin D with vitamin K that affect arterial calcification and
hypervitaminosis. Furthermore, it is possible that dosages exceeding the recommendations for vitamin D (i.e.
dosages up to 4000-5000 IU/day), in combination with 50 to 1000 mcg/day of vitamin K1 and K2 could aid athletic
performance. This review will investigate these topics, and specifically their relevance to athletic performance.
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Introduction
Vitamin D, a fat-soluble vitamin, was first discovered in
cod liver oil [1] and has since been identified as an
essential vitamin, acting as a precursor steroid to a host
of metabolic and biological processes. Once converted
into its biologically-active form, 1,25-dihydroxyvitamin
D [2], it regulates the expression of over 900 gene vari-
ants [3]. These gene expressions have been shown to
have significant impact on a wide variety of health and
performance-related variables, such as exercise-induced
inflammation, tumour suppressor genes, neurological
function, cardiovascular health, glucose metabolism,
bone health and skeletal muscle performance [4–10].
Surprisingly enough, 88.1 % of the world’s population
has inadequate vitamin D levels [11]. Deficiency has
been shown to be linked to a variety of adverse psycho-
logical and health outcomes, such as suicidal thoughts
[12], depression [13], cognitive decline and neurological
impairment [14], and an increased risk of cancer [15].
Furthermore, individuals with inefficient vitamin D
stores have an increased risk of bone disorders like
spondyloarthritis [16], rickets [1, 17], and fractures due
to higher bone resorption from an overproduction of
parathyroid hormone (PTH) [18, 19]. Lastly, deficiency
has catabolic effects on muscle tissue [20], causes
muscle weakness [21], and impairs cross-bridge forma-
tion [22], all of which could impair athletic perform-
ance. Due to the increase in enzymatic activity of exercise
[23], athletes may be as susceptible, if not more suscep-
tible to becoming vitamin D deficient when compared to
the general population. A recent meta-analysis pooling 23
studies with 2313 athletes found that 56 % of athletes had
inadequate vitamin D levels [24]. Because of the high
prevalence of vitamin D deficiency [25] and its effects on
human physiology, this review is aimed to identify the role
of vitamin D in athletic performance (for health related as-
pects of vitamin D, see [11, 18, 26, 27]). This review will
cover how vitamin D is metabolized in the body, its
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potential roles in athletic performance, sources of vitamin
D, differences between vitamin D2 and vitamin D3, opti-
mal levels of vitamin D for athletes, and strategies to
achieve these levels and prevent toxicity by nutrient-
nutrient interactions.
Metabolism of vitamin D
Vitamin D travels in the bloodstream bound to vitamin D-
binding proteins [28] and undergoes a three-stage process
of key enzymatic reactions [Fig. 1]: 25-hydroxylation, 1α-
hydroxylation and 24-hydroxylation [18, 29]. The steroid
precursor vitamin D3 first travels to the liver where it is
hydroxylated to 25-hydroxyvitamin D [25(OH)D] by 25-
hydroxlayse, which is mediated by the cytochrome P450
enzymes, CYP27A1 (in the mitochondria) and CYP2R1
[29]. This 25(OH)D is then hydroxylated by CYP27B1
(1α-hydroxylation) [29]. This final step occurs primarily in
the kidney [18], but various other tissues, namely skeletal
muscle, have also been shown to express CYP24A1 en-
zymes, where 25(OH)D becomes the active hormonal
form, 1,25-dihydroxyvitamin D [29]. 1,25-dihydroxyvita-
min D then interacts with vitamin D receptors (VDR),
which are located in almost every tissue in the body
[30, 31], and is then transcribed into the cell and binds
to vitamin D response elements (VDREs) located in
DNA [18]. If 1,25-dihydroxyvitmain D does not interact
with VDREs, it is further degraded by CYP24A1 (24-hy-
droxylase) to the inactive form, calcitroic acid [29].
Vitamin D and performance
Vitamin D3 receptors exist in human skeletal muscle tis-
sue [30, 31], indicating that 1,25-dihydroxyvitamin D has
a direct effect on skeletal muscle activity. Research on
the muscle effects of vitamin D3 [32] is limited to dis-
eased populations [20, 33], or healthy untrained adults
[34]. Until recently, a few reviews and meta-analyses
have shown that increasing serum 25(OH)D levels in a
given population have a positive effect on muscle
strength, power and mass [33–35] but the only study
that examined the effects in athletes [36], had mixed re-
sults. In addition, von Hurst and Beck [36] concluded that
the optimal intake and serum concentration of 25(OH)D
have yet to be identified in the athletic population.
Maximal oxygen uptake
Vitamin D receptors (VDR) are present in cardiac muscle
and vascular tissue [7], indicating that 1,25-dihydroxyvita-
min D might influence maximal oxygen uptake (VO2max)
via the ability to transport and utilize oxygen within the
blood to various tissues. Multiple correlative studies
showed a positive correlation between VO2max and serum
25(OH)D concentration in non-athletes [Table 1] [37–39].
However many confounding variables were not addressed,
such as concomitant multivitamin [38] and supplement
intake [37, 39]. Studies performed in athletes are conflict-
ing. Koundourakis and his colleagues [40] found that there
was a significant correlation between 25(OH)D levels and
performance parameters in 67 Caucasian male profes-
sional soccer players (age 25.6 ± 6.2). A linear relationship
was seen between pre- and post- offseason measurements
of 25(OH)D and muscle strength indicated by squat jump
(SJ), countermovement jump (CMJ), sprinting ability (10-
and 20- m sprint) and VO2max [40]. A more recent publi-
cation by Fitzgerald et al. [41], concluded that there was
no association between 25(OH)D levels and an individual’s
Fig. 1 Metabolism of vitamin D3 derived from the diet, pharmacological analogs and natural sunlight to the major circulating metabolite of
vitamin D (25-hydroxyvitamin D), and subsequently to the active hormonal form, 1,25 dihydroxyvtiamin D
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VO2max in 52 Caucasian competitive ice hockey players
[41]. Additionally, the correlation commonly seen be-
tween the serum 25(OH)D concentrations and VO2max
is inversely related to increases in physical activity and
training status [39]. Forney and her colleagues [42]
recently investigated the association between serum
Table 1 Vitamin D correlation and intervention studies on Maximal Oxygen Uptake (VO2max)
Author Reference
#
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respectively) and
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25(OH)D, VO2max and training status in 39 physically-
active college students (20 men, 19 women). They
showed that the participants with higher (>35 ng-mL-1)
serum 25(OH)D levels had a significantly higher
VO2max (+20 %) than the low (<35 ng-mL-1) serum
25(OH)D group [42]. However, this correlation was
limited to males only.
Intervention trials in the athletic population are scarce.
To our knowledge, only one exists looking at the effects of
vitamin D supplementation on VO2max. Jastrzebski [43]
performed a single-blinded trial of supplementation with
6000 IU/day of vitamin D3 versus a placebo during an 8-
week training cycle in 14 elite lightweight rowers with suf-
ficient 25(OH)D concentrations (>30 ng/mL). They dem-
onstrated a significantly increase in VO2max (12.1 % and
10.3 %, respectively) and 25(OH)D concentrations by
400 % (~120 ng/mL). The authors concluded that supple-
mentation of vitamin D3 during the 8-week training
period significantly improved aerobic metabolism in the
elite rowers [43]. Further research is needed to test
whether an ergogenic effect exists in athletes who are se-
verely deficient in serum 25(OH)D, and if supraphysiologi-
cal dosages of vitamin D3, such as that used by Jastrzebski,
have an ergogenic effect in vitamin D replete athletes in
other sport disciplines.
The specific mechanism by which increased levels of
25(OH)D affect VO2max remains unclear [39], however
this phenomenon could be due to the fact that the CYP
enzymes that activate vitamin D3 into 1,25-dihydroxyvita-
min D3 have heme-containing proteins [44] and could po-
tentially affect the binding affinity of oxygen to hemoglobin.
Recovery
The ability to recover rapidly is important for athletes
to train at high intensities more frequently. Human
skeletal muscle tissue responds to training stimuli and/
or tissue damage through remodeling [45–47]. During
recovery, 1,25-dihydroxyvitamin D increases the myo-
genic differentiation and proliferation [48] and down-
regulates myostatin, an inhibitory regulator of muscle
synthesis of C2C12 myoblasts in culture [49]. Stratos
and colleagues [50] showed this marked increase in
skeletal muscle regeneration in a crushed soleus muscle
(in vivo) of 56 male Wistar rats (300 to 325 g body
weight), after a supraphysiological dose of ~100,000 IU
of vitamin D. They [50] separated rats into a high
(332,000 IU/kg) and low (33,200 IU/kg) dose groups
and examined recovery response times to the crushed
soleus muscle. When compared to the low dose group,
the high dose group had a significant attenuation of
apoptosis four days post-injury, indicative of an in-
crease in cellular matrix proteins [50]; which is crucial
for skeletal tissue repair [51]. This increase in cellular
turnover rate led to the enhanced recovery time, an in-
crease in tetanic force production (only 10 % lower
than the non-injured limb), and an increase in twitch
force when compared to the control group [50]. As
murine models display regenerative capacities that
exceed those of humans, it is important to note the
limitations of extending the aforementioned findings to
humans; however, the finding that vitamin D supplemen-
tation enhances the recovery in peak isometric force
shortly after intense exercise was recently supported in
much lower doses in modestly-active humans [52].
In a randomized, double-blind, placebo-controlled
study, Barker et al. [52] demonstrated that 4000 IU/day
for 35 days of vitamin D in healthy and moderately ac-
tive adults attenuated the inflammatory biomarkers ala-
nine (ALT) and aspartate (AST) immediately following
10 sets of 10 repetitions of peak isometric force
eccentric-concentric jumps. Furthermore, although peak
power output decreased in both the groups, the supple-
mentation group only decreased by 6 %, while the pla-
cebo group’s power decreased by 32 % immediately
post-exercise [52]. This discrepancy persisted at 48 h
[52]. Further research examining higher dosages would
be warranted to determine if recovery and power output
are improved to a greater degree [Table 2].
Force and power production
Vitamin D3 has also been shown to increase force and
power output of skeletal muscle tissue [19], perhaps
through the sensitization of calcium binding sites on the
sarcoplasmic reticulum, leading to an enhanced cross-
bridge cycling and muscular contraction [53]. There is
further evidence that vitamin D3 might also potentially
increase both size and number of type II muscle fibers
[20, 54, 55]. These findings have only been supported in
mobility-limited elderly (≥65 years old) women [55], and
have yet to be tested in the athletic population. On the
other hand, increases in force and power production have
been studied in athletes with positive results during a ran-
domized placebo-controlled study in 10 male professional
soccer players [56]. After an 8-week long intervention of
either receiving 5000 IU/day of vitamin D3 or a placebo,
the vitamin D3 group had a significant increase in serum
25(OH)D levels and a significant improvement in both
their 10-m sprint times and vertical jump when compared
to the placebo group [56]. Confounding variables were
well-controlled, in that the authors instructed the athletes
to maintain current nutritional intake, and excluded any
athlete who was taking a multivitamin, vitamin D, fish oil
and/or were regular sunbed users or who just returned
from a vacation in a sunlight enriched climate. However,
other studies have shown no significant benefit of vitamin
D supplementation in athletes with moderately deficient
or adequate levels [10, 41, 42], indicating that these
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performance benefits might be limited to individuals with
significant vitamin D deficiency [Table 3].
Vitamin D and testosterone
Testosterone is an endogenous hormone important
for muscular adaptations to training. Naturally low
testosterone levels in young men have been linked to de-
creases in protein anabolism, strength, beta-oxidation,
and an increase in adipose deposition [57]. Thus, ath-
letes endeavour to optimize natural androgenic produc-
tion. A recent cross-sectional study done on 2299 older
men (62 ± 11 years of age) showed that 25(OH)D levels
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correlated with testosterone and androgen levels in men
[58]. Low testosterone, or hypogonadism, was identified
in 18 % of the participants, and these men had signifi-
cantly lower mean 25(OH)D levels than the rest of the
population. Furthermore, only 11.4 % of the sample had
sufficient levels of vitamin D.
Additionally a 12-month, double-blind, randomized
control trial in 54 non-diabetic males demonstrated that
the group receiving 3332 IU/day of vitamin D had a sig-
nificant increase in circulating 25-hydroxyvitamin D, total
testosterone, bioactive testosterone, and free testosterone
levels [59]. These findings support the notion that elevat-
ing 25(OH)D levels may augment testosterone production
in non-diabetic male subjects, which indicates that vitamin
D supplementation might have ergogenic potential
through the enhancement of endogenous testosterone
production. More research is required in order to investi-
gate this potential role of vitamin D and testosterone
levels in various study populations [Table 4].
The specific mechanism of action of 25(OH)D on tes-
tosterone in men could potentially be related to two pro-
cesses: inhibited testosterone aromatization and enhanced
androgen binding. Evidence for both of these mechanisms
comes from animal models. Specifically, higher 25(OH)D
levels inhibit gonadal aromatization of testosterone in
VDR knockout mice [60]. Secondly, VDR and vitamin D
metabolizing enzymes have been located in human and
rat testis and have been shown to enhance the affinity of
androgen binding receptors [57, 61, 62]. This effect in-
creases the rate at which androgens can bind to
testosterone-producing glands resulting in higher concen-
trations of steroid hormones, leading to an increase in




Humans acquire vitamin D from two different sources,
endogenous production after sun exposure, or via the diet
(from food or supplementation). Unlike the metabolism of
dietary vitamin D, the synthesis of vitamin D3 by the skin
is a non-enzymatic biological process [65]. Once the skin
is exposed to the Sun’s ultraviolet B (UVB) radiation, it
then converts stored 7-dehydrocholesterol into circulating
vitamin D3, 25(OH)D [29] and other isomers [66]. The
amount of UVB exposure determines the amount and the
specific isomers of vitamin D3 that will form [66, 67]. The
recommended dosage of sunlight exposure during the
summer is five to 20 min per day to 5.0 % of exposed skin
at a UVB radiation of 290–315 nm [68, 69] two to three
times a week [70]. Additionally, it has been shown that
15 min of adequate (290–315 nm) UVB exposure during
the summer months in a bathing suit can produce 10,000
to 20,000 IU of vitamin D3 [71]. However, multiple factors
can affect the rate and synthesis of vitamin D3 [Table 5]
[25, 66, 72–74].
Diet
Vitamin D derived from diet and supplementation
comes in two forms, the plant-based vitamin D2 (ergo-
calciferol), and the more bioavailable mammal and fish
source, vitamin D3 (cholecalciferol) [75]. Vitamin D can
be found in various food products [Fig. 2] [76], such as
fortified cereals and milk, natural foods like salmon, or
through various vitamin D analogues produced synthet-
ically in a laboratory [Table 6] [18, 76]. Both sources are
considered prohormone compounds, capable of increas-
ing circulating 25(OH)D, after they have been converted
by the enzymatic reactions described earlier.
Dosage for optimal performance
Both D2 and D3 are capable of increasing plasma
25(OH)D concentration, but vitamin D3 might be more
effective than vitamin D2 [75, 77, 78]. When compared
to vitamin D3, vitamin D2 is less stable, less bioavailable
with increasing age, and it has been shown in multiple
clinical studies that the amount of vitamin D2 absorbed
is significantly lower than with vitamin D3. Furthermore,
vitamin D2 has a lower affinity to VDRs [54, 75, 77–79]
and a higher rate of deactivation once hydroxylated in
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the kidney due to side-chain variations [77]. Lastly, an
epidemiological study during the winter months in Dun-
edin, New Zealand investigated the effects of 1000 IU/
day of either vitamin D2 or vitamin D3 supplementation
over a 25-week period in 95 healthy, adult participants
(18–50 years old) [78]. The participants who received
the vitamin D2 supplement had a larger decrease in
serum 25(OH)D (74 nmol/L to 50 nmol/L) levels than
those who took vitamin D3 (80 nmol/L to 72 nmol/L)
[78]. However, both results show that 1000 IU/day of
vitamin D was inadequate to increase serum 25(OH)D
concentrations and actually caused a decline with both
isoforms.
With vitamin D3 proving more efficacious, the opti-
mal dosage varies depending on the individual and the
institution providing the guidelines. The Institute of
Medicine (IOM) recommends 400–800 IU/day for
children, adults and individuals >70 years of age to
maintain serum vitamin D at >50 nmol/L [11, 80, 81].
Alternatively, the Endocrine Society (ES) recommends
a slightly higher intake, with dosages of 400–1000 IU/
day for infants, 600–1000 IU/day for children, and
1500-2000 IU/day for adults in order to maintain
adequate serum vitamin D concentrations of 75 nmol/L
[82]. These recommendations correspond with a review
in 2004 [83], stating that 70 nmol/L is the lowest desir-
able serum concentration to prevent adverse health ef-
fects. Other recommendations have suggested optimal
levels may be 90 to greater than 120 nmol/L [86, 87],
based on estimations made from that of levels seen in in-
dividuals inhabiting very sunlight-rich environments [84]
and/or have shown optimal lower-extremity function [85].
The definitions of hypovitaminosis or hypervitaminosis
are more controversial. The IOM defines inadequate
stores of 25(OH)D as 30–50 nmol/L, and deficiency as
25(OH)D <30 nmol/L [88], and sets the upper limit of
dietary intake of vitamin D to 4000 IU/day [69]. The ES
on the other hand, defines vitamin D deficiency at levels
of 25(OH)D <50 nmol/L, insufficiency as 25(OH)D be-
tween 51 to 74 nmol/L [89], and sets the upper limit of
dietary intake of vitamin D to 10,000 IU/day [19]. How-
ever, recent reviews have suggested that this is more of a
theoretical concern [72, 83, 84, 90]. The optimal vitamin
D dosage and level are clearly controversial [88, 91]. Fur-
thermore, the optimal levels needed for athletic perform-
ance have not yet been determined. Growing evidence has
supported that 600–800 IU/day may not be sufficient for
optimal levels of vitamin D, especially for the athletic
population [92], since serum 25(OH)D concentrations
Table 5 Factors affecting the rate and synthesis of
endogenously produced vitamin D
Seasonal Variations in UVB Exposure




Thick Ozone Layers due to Pollution
Darker Skin Pigmentation (higher melanin [natural sun-block] levels)
Higher Adipose Tissue (obesity)
Older Age
Utilization of Sun-block
Fig. 2 Dietary sources of vitamin D3 and D2 through whole (natural) or fortified food sources
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greater than 100 nmol/L have been proposed to be opti-
mal for lower body skeletal muscle function [85] and low
vitamin D levels are linked to increased bone turnover, in-
creasing the risk of stress fractures [93]. It has been shown
that it takes roughly 2000 to 5000 IU/day of vitamin D
from all available sources in order to optimize bone health
by maintaining serum 25(OH)D levels of 75 to 80 nmol/L
[84, 85, 94, 95]. Furthermore, this dosage would be un-
attainable from natural UVB exposure during the months
of October to April when residing in latitudes of 42.2 to
52° N [96] which is indicated by the high prevalence of
vitamin D deficient indoor and outdoor athletes in a
multitude of disciplines [24, 97–99]. Lastly, studies that
have shown to improve athletic prowess utilize dosages
higher than 3000 IU/day, but none have yet to reach levels
greater than 100 nmol/L. Thus, it remains unclear, but
athletes may benefit from 25(OH)D levels ≥100 nmol/L in
order to increase skeletal muscle function and reduce the
risk of stress fractures.
However, no study to date has looked at the effects of
vitamin D supplementation and skeletal muscle function
in the athletic population with 25(OH)D levels of
≥100 nmol/L [36]. Additionally, the previous perform-
ance intervention studies presented in this review
supplemented with dosages far greater than the recom-
mended dosages of 600–2000 IU/day (e.g., 5000 IU/day
of D3) and 1000 IU/day of vitamin D3 during the winter
months is not enough to prevent a decline in serum
25(OH)D stores [78].
Toxicity & hypercalcemia
Although it has been reported that vitamin D toxicity
might occur with dosages of ≥10,000 IU/day for an ex-
tended period [71, 84], producing adverse effects like hy-
percalcemia, the level of vitamin D causing toxicity is
unclear [71, 100], and due to ethical reasons, no pro-
spective studies have analyzed the effect of vitamin D in-
toxication in humans. Recently, an accidental overdose
of 2,000,000 IU of vitamin D3 in two elderly patients did
not cause adverse effects and only elevated blood cal-
cium levels slightly [101]. More importantly, adverse
effects have only been reported at serum concentrations of
25(OH)D above 200 nmol/L, which would take daily dos-
ages of 40,000 IU or more of vitamin D to achieve [84], and
serum concentrations of 25(OH)D of <140 nmol/L have
not been correlated with hypercalcemia. 1,25-dihydroxyvi-
tamin D works synergistically with calcium and allows it to
be absorbed from the gastrointestinal tract and stimulates
mature osteoblasts to produce receptor activator nuclear
factor-kB ligand (RANKL) [102]. RANKL in turn stimulates
mineralization and bone resorption via osteoclastogenesis.
Increased levels of 25(OH)D can accelerate this process,
causing a rise in calcium concentration in the blood, a
higher absorption rate of calcium by the kidneys, and could
potentially lead to kidney stones and/or potential vascular
calcification [103].
Vitamin K
Any discussion of vitamin D toxicity merits mention of
vitamin K. As with calcium, vitamin K works synergistic-
ally with vitamin D to regulate bone resorption, activa-
tion and distribution [104]. Vitamin K carboxylates the
newly-formed ostecalcin proteins that are produced in
mature bone cells and are tightly regulated by vitamin D
[105]. Once the protein is carboxylated, it interacts with
calcium ions in bone tissue [106] and has a significant
effect on bone mineralization, formation, the prevention
of bone loss, and potentially the stoppage of fractures in
women [105, 107–111]. However, when levels of vitamin
K are inadequate, the ostecalcin production is not sup-
pressed [109]. This situation facilitates a build-up of un-
carboxylated (inactive) ostecalcin proteins in bone, leading
to a potential increase in calcium release from bone and
the deposition of calcium into soft tissues (causing arterial
calcification) [112, 113]. Thus, vitamin D3 toxicity might
occur only in the absence of sufficient vitamin K stores.
Table 6 Vitamin D sources from pharmacological analogs
Pharmacological supplements Serving size Type of vitamin D Vitamin D (1U)
Prescription
Pill 1 pill D2 or D3 50,000
Liquid 1 ml D2 or D3 8000
Over The Counter
Multi-Vitamin 1 serv D2 or D3 1000
400 IU Pill 1 pill D2 or D3 400
800 IU Pill 1 pill D2 or D3 800
1000 IU Pill 1 pill D2 or D3 1000
2000 IU Pill 1 pill D2 or D3 2000
5000 IU Pill 1 pill D2 or D3 5000
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Recommended dosages of vitamin K range from 50
mcg to 1000 mcg [108]. However, these recommenda-
tions are controversial since vitamin K stores are rapidly
depleted without constant supply [114] and like vitamin
D, vitamin K also has two variants: K1 and K2. Sources
of vitamin K can be found in pharmacological analogues
and naturally in the diet. Vitamin K1, the most abundant
form found in an individual’s diet [115], is high in green
leafy cruciferous vegetables, fruits, various vegetable oils
and beans [114]. Vitamin K2, the more bioavailable form
of vitamin K [114], comes in a variety of fish, offal, meat,
dairy products, fermented cheese (e.g., blue cheese), and
fermented products like natto (fermented soybeans, a
Japanese delicacy) [116].
Both forms play different roles in the body [117], but
the IOM has set the recommended dietary intake only for
the K1 isoform (90 mcg/day for women and 120 mcg/day
for men), with no upper limit, and has yet to set any diet-
ary recommendation for vitamin K2 [114]. Specifically,
vitamin K1 has a key role in the carboxylation of various
blood clotting proteins, where vitamin K2 is essential for
the carboxylation and activation of osteocalcin and matrix
Gla protein (MGP) (an essential protein needed to prevent
soft tissue calcification) [118]. More importantly, one of
the vitamin K2 variants, MK-4, is more effective at mitigat-
ing osteoclast formation and the negative health effects of
vitamin D overdose [114, 115]. Furthermore, 10 mg/day
(10,000 mcg) of synthetic vitamin K1 (phytonadione, sold
as Konakion® [119]) has been shown to be beneficial for
elite female marathon runners by increasing bone forma-
tion and preventing bone loss [120] and mega-doses of
45 mg/day (45,000 mcg) of MK-4 in combination with
vitamin D3 could prevent osteoporosis in postmenopausal
women [102, 109]. Thus, although MK-4 might have the
greatest effect on carboxylation of osteocalcin, both vita-
min K1 and K2 interact with each other in order to
optimize bone health and are essential to the human body.
Further research in athletic populations should focus on
the optimal dosage for vitamin D3 in combination with
vitamin K.
Conclusion
In summary, an interesting theme has emerged from
animal studies that supraphysiological dosages of vita-
min D3 have potential ergogenic effects on the human
metabolic system and lead to multiple physiological
enhancements. These dosages could increase aerobic
capacity, muscle growth, force and power production,
and a decreased recovery time from exercise. These
dosages could also improve bone density. However,
both deficiency (12.5 to 50 nmol/L) and high levels of
vitamin D (>125 nmol/L) can have negative side effects,
with the potential for an increased mortality [121].
Thus, maintenance of optimal serum levels between 75
to 100 nmol/L [11, 86] and ensuring adequate amounts
of other essential nutrients including vitamin K are
consumed, is key to health and performance. Coaches,
medical practitioners, and athletic personnel should
recommend their patients and athletes to have their
plasma 25(OH)D measured, in order to determine if
supplementation is needed. Based on the research pre-
sented on recovery, force and power production, 4000-
5000 IU/day of vitamin D3 in conjunction with a mix-
ture of 50 mcg/day to 1000 mcg/day of vitamin K1 and
K2 seems to be a safe dose and has the potential to aid
athletic performance. Lastly, no study in the athletic
population has increased serum 25(OH)D levels past
100 nmol/L, (the optimal range for skeletal muscle
function) using doses of 1000 to 5000 IU/day. Thus,
future studies should test the physiological effects of
higher dosages (5000 IU to 10,000 IU/day or more) of
vitamin D3 in combination with varying dosages of
vitamin K1 and vitamin K2 in the athletic population
to determine optimal dosages needed to maximize
performance.
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